NCO-700

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNCO-700
Drug Alias NameNCO-700
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide hydrolase inhibitors
TargetsPeptide hydrolase
Therapy Area/IndicationsMyocardial IschemiaArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Chemiphar Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Chemiphar Co Ltd
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A